This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Zoetis Inc (ZTS)

NYSE: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 339.00M 587.00M 503.00M 436.00M
Operating Gains/Losses 3.00M 2.00M 2.00M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -58.00M 69.00M -99.00M -65.00M
(Increase) Decrease in Inventories -262.00M -16.00M -104.00M -318.00M
(Increase) Decrease In Other Current Assets -9.00M -2.00M -24.00M -5.00M
(Decrease) Increase In Payables 17.00M -210.00M -82.00M 96.00M
(Decrease) Increase In Other Current Liabilities 104.00M 2.00M 205.00M 143.00M
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 416.00M 39.00M 48.00M 41.00M
Net Cash From Continuing Operations 664.00M 626.00M 681.00M 454.00M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 664.00M 626.00M 681.00M 454.00M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -224.00M -180.00M -184.00M -126.00M
Acquisitions -883.00M 0.00 -4.00M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -8.00M -7.00M 9.00M -9.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.11B -187.00M -179.00M -135.00M
Issuance of Debt 1.24B 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 0.00 0.00
Repayment of Long-Term Debt -119.00M 0.00 0.00 0.00
Repurchase of Capital Stock -203.00M 0.00 0.00 0.00
Payment of Cash Dividends -168.00M -146.00M -98.00M -63.00M
Other Financing Charges, Net 9.00M -8.00M -102.00M -15.00M
Net Cash From Financing Activities 755.00M -154.00M -200.00M -78.00M
Effect of Exchange Rate Changes -32.00M -13.00M -9.00M -3.00M
Net Change in Cash & Cash Equivalents 272.00M 272.00M 293.00M 238.00M
ZTS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ZTS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 7 7
Moderate Buy 0 0 0 0
Hold 4 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ZTS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs